Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07036874

Non-invasive Assessment for Outcome Prediction in Patients With Hepatocellular Carcinoma

Sponsor: Chinese University of Hong Kong

View on ClinicalTrials.gov

Summary

This is a single-centre, prospective cohort study. Consecutive patients with compensated liver disease and hepatocellular carcinoma (HCC) for curative-intent treatment will be invited to this study. The study follow-up duration will be five years. The primary outcome is the composite of incident high-risk varices, hepatic decompensation and liver-related mortality. The participants will undergo transient elastography at baseline and then half-yearly post-HCC curative treatment; and oesophagogastroduodenoscopy (OGD) at baseline and then at year 1, 3 and 5 post-HCC curative treatment. Clinical assessments and laboratory tests will also be done at baseline and every 6 months until year 5 to identify any clinical events.

Official title: Validation of Baveno VII Criteria and Spleen Stiffness Measurement on Outcome Prediction in Patients With Hepatocellular Carcinoma

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

159

Start Date

2024-11-04

Completion Date

2030-12

Last Updated

2025-06-29

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

transient elastography and oesophagogastroduodenoscopy

Liver and spleen stiffness will be measured by transient elastography. Varices will be identified by oesophagogastroduodenoscopy.

Locations (1)

Prince of Wales Hospital

Hong Kong, Hong Kong